These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 9820535)
1. Evaluation of IL-12 in immunotherapy and vaccine design in experimental Mycobacterium avium infections. Silva RA; Pais TF; Appelberg R J Immunol; 1998 Nov; 161(10):5578-85. PubMed ID: 9820535 [TBL] [Abstract][Full Text] [Related]
2. IL-12 promotes drug-induced clearance of Mycobacterium avium infection in mice. Doherty TM; Sher A J Immunol; 1998 Jun; 160(11):5428-35. PubMed ID: 9605144 [TBL] [Abstract][Full Text] [Related]
3. [Novel vaccines against M. tuberculosis]. Okada M Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920 [TBL] [Abstract][Full Text] [Related]
4. Endogenously produced IL-12 is required for the induction of protective T cells during Mycobacterium avium infections in mice. Castro AG; Silva RA; Appelberg R J Immunol; 1995 Aug; 155(4):2013-9. PubMed ID: 7636252 [TBL] [Abstract][Full Text] [Related]
5. Anti-CD3 single-chain Fv/interleukin-18 fusion DNA induces anti-mycobacterial resistance via efficient interferon-gamma production in BALB/c mice infected with Mycobacterium avium. Kim SH; Cho D; Kim TS Vaccine; 2006 Apr; 24(16):3365-73. PubMed ID: 16481075 [TBL] [Abstract][Full Text] [Related]
6. The role of interleukin-12 in acquired immunity to Mycobacterium tuberculosis infection. Cooper AM; Roberts AD; Rhoades ER; Callahan JE; Getzy DM; Orme IM Immunology; 1995 Mar; 84(3):423-32. PubMed ID: 7751026 [TBL] [Abstract][Full Text] [Related]
7. [Frontier of mycobacterium research--host vs. mycobacterium]. Okada M; Shirakawa T Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793 [TBL] [Abstract][Full Text] [Related]
8. Role of interleukin-6 in the induction of protective T cells during mycobacterial infections in mice. Appelberg R; Castro AG; Pedrosa J; Minóprio P Immunology; 1994 Jul; 82(3):361-4. PubMed ID: 7959868 [TBL] [Abstract][Full Text] [Related]
10. Exposure to Mycobacterium avium decreases the protective effect of the DNA vaccine pVAXhsp65 against Mycobacterium tuberculosis-induced inflammation of the pulmonary parenchyma. Martins DR; Pelizon AC; Zorzella-Pezavento SF; Seger J; Santos Junior RR; Fonseca DM; Justulin LA; Silva CL; Sartori A Scand J Immunol; 2011 Apr; 73(4):293-300. PubMed ID: 21214611 [TBL] [Abstract][Full Text] [Related]
11. Improving recombinant MVA immune responses: potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma. Abaitua F; Rodríguez JR; Garzón A; Rodríguez D; Esteban M Virus Res; 2006 Mar; 116(1-2):11-20. PubMed ID: 16214252 [TBL] [Abstract][Full Text] [Related]
12. IL-2 and IL-12 act in synergy to overcome antigen-specific T cell unresponsiveness in mycobacterial disease. de Jong R; Janson AA; Faber WR; Naafs B; Ottenhoff TH J Immunol; 1997 Jul; 159(2):786-93. PubMed ID: 9218596 [TBL] [Abstract][Full Text] [Related]
13. [TH1 response in the experimental infection with Trypanosoma cruzi]. Cardoni RL; Antúnez MI; Abrami AA Medicina (B Aires); 1999; 59 Suppl 2():84-90. PubMed ID: 10668248 [TBL] [Abstract][Full Text] [Related]
14. Plasmid interleukin-23 (IL-23), but not plasmid IL-27, enhances the protective efficacy of a DNA vaccine against Mycobacterium tuberculosis infection. Wozniak TM; Ryan AA; Triccas JA; Britton WJ Infect Immun; 2006 Jan; 74(1):557-65. PubMed ID: 16369012 [TBL] [Abstract][Full Text] [Related]
15. Therapeutic efficacy of a tuberculosis DNA vaccine encoding heat shock protein 65 of Mycobacterium tuberculosis and the human interleukin 2 fusion gene. Changhong S; Hai Z; Limei W; Jiaze A; Li X; Tingfen Z; Zhikai X; Yong Z Tuberculosis (Edinb); 2009 Jan; 89(1):54-61. PubMed ID: 19056317 [TBL] [Abstract][Full Text] [Related]
16. Co-administration of IL-12 DNA with rORFF antigen confers long-term protective immunity against experimental visceral leishmaniaisis. Tewary P; Saxena S; Madhubala R Vaccine; 2006 Mar; 24(13):2409-16. PubMed ID: 16413950 [TBL] [Abstract][Full Text] [Related]
17. The combination of plasmid interleukin-12 with a single DNA vaccine is more effective than Mycobacterium bovis (bacille Calmette-Guèrin) in protecting against systemic Mycobacterim avium infection. Martin E; Kamath AT; Briscoe H; Britton WJ Immunology; 2003 Jun; 109(2):308-14. PubMed ID: 12757627 [TBL] [Abstract][Full Text] [Related]
18. Enhanced protection against tuberculosis by vaccination with recombinant Mycobacterium microti vaccine that induces T cell immunity against region of difference 1 antigens. Brodin P; Majlessi L; Brosch R; Smith D; Bancroft G; Clark S; Williams A; Leclerc C; Cole ST J Infect Dis; 2004 Jul; 190(1):115-22. PubMed ID: 15195250 [TBL] [Abstract][Full Text] [Related]
19. IL-12 delivery from recombinant vaccinia virus attenuates the vector and enhances the cellular immune response against HIV-1 Env in a dose-dependent manner. Gherardi MM; Ramirez JC; Rodríguez D; Rodríguez JR; Sano G; Zavala F; Esteban M J Immunol; 1999 Jun; 162(11):6724-33. PubMed ID: 10352291 [TBL] [Abstract][Full Text] [Related]
20. [Immunogenicity of interleukin 12 and DNA vaccine prime-BCG boost against Mycobacterium tuberculosis]. Gao L; Bao L; Hao M; Zhang L; Qin ZF Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Jul; 39(4):535-9. PubMed ID: 18798487 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]